Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 74711-43-6
2. 2-(10-oxo-10,11-dihydrodibenzo[b,f]thiepin-2-yl)propanoic Acid
3. 89482-00-8
4. Soleton
5. Cn-100
6. Soreton
7. Peon
8. Zaltoprofen [inn]
9. Cn 100
10. Zaltoprofene
11. Zaltoprofeno
12. Zaltoprofenum
13. Zaltoprofen [inn:jan]
14. Zaltoprofene [inn-french]
15. Zaltoprofenum [inn-latin]
16. 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic Acid
17. Zaltoprofeno [inn-spanish]
18. 10,11-dihydro-alpha-methyl-10-oxodibenzo(b,f)thiepin-2-acetic Acid
19. H8635ng3py
20. Cn100
21. Zaltoprofen (+-)-
22. 2-(6-oxo-5h-benzo[b][1]benzothiepin-3-yl)propanoic Acid
23. Zaltoprofen Sodium Salt
24. Ncgc00183878-01
25. Dsstox_cid_29002
26. Dsstox_rid_83267
27. Dsstox_gsid_49076
28. Zaltoprofen (unspecified)
29. 10,11-dihydro-alpha-methyl-10-oxodibenzo[b,f]thiepin-2-acetic Acid
30. 2-(10-oxo-10,11-dihydrodibenzo-[b,f]thiepin-2-yl)propanoic Acid
31. Smr003500719
32. Cas-74711-43-6
33. Einecs 277-973-5
34. Unii-h8635ng3py
35. (+-)-10,11-dihydro-alpha-methyl-10-oxodibenzo(b,f)thiepin-2-acetic Acid
36. Peon (tn)
37. Zaltoprofen [mi]
38. Zaltoprofen [jan]
39. (+-)-2-(10,11-dihydro-10-oxodibenzo(b,f)thiepin-2-yl)propionic Acid
40. Zaltoprofen (jp17/inn)
41. Zaltoprofen [mart.]
42. Zaltoprofen [who-dd]
43. Mls004774050
44. Mls006010214
45. Schembl124047
46. Amy421
47. Chembl1765291
48. Dtxsid0049076
49. Chebi:32306
50. Hms3656j14
51. Hms3744o11
52. Hms3885e03
53. Bcp02387
54. Hy-b0619
55. Tox21_113634
56. 10,11-dihydro-alpha-methyl-10-oxo-dibenzo[b,f]thiepin-2-acetic Acid
57. Mfcd00864323
58. S3008
59. Zc-102
60. Akos015895991
61. Dibenzo(b,f)thiepin-2-acetic Acid, 10,11-dihydro-alpha-methyl-10-oxo-
62. Tox21_113634_1
63. Ccg-267450
64. Db06737
65. Gs-3949
66. Ncgc00263585-01
67. Ncgc00263585-04
68. Ac-32652
69. Ft-0630837
70. Ft-0656731
71. Sw219801-1
72. Z0021
73. D01547
74. Ab01565848_02
75. 711z436
76. A838204
77. F0001-2421
78. 2-(6-oxo-5a,6-dihydrodibenzo[b,f]thiepin-3-yl)propanoic Acid
79. 10,11-dihydro-alpha-methyl-10-oxo-dibenzo[b,f]thiepin-2-aceticacid
80. 2-(10,11-dihydro-10-oxodibenzo [b,f] Thiepin-2-yl)propionic Acid
81. 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)-propionic Acid
82. 2-(10-oxo-10,11-dihydro-dibenzo[b,f]thiepin-2-yl)-propionic Acid
83. (alphar)-10,11-dihydro-alpha-methyl-10-oxodibenzo[b,f]thiepin-2-acetic Acid
84. (alphas)-10,11-dihydro-alpha-methyl-10-oxodibenzo[b,f]thiepin-2-acetic Acid
85. 1166864-09-0
86. 2-{10-oxo-2-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-6-yl}propanoic Acid
Molecular Weight | 298.4 g/mol |
---|---|
Molecular Formula | C17H14O3S |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 298.06636548 g/mol |
Monoisotopic Mass | 298.06636548 g/mol |
Topological Polar Surface Area | 79.7 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 422 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Zaltoprofen has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-[2-(6-oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoyloxy]oxane-2-carboxylic acid, 10-hydroxy-zaltoprofen, and Zaltoprofen S-oxide.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
35
PharmaCompass offers a list of Zaltoprofen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zaltoprofen manufacturer or Zaltoprofen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zaltoprofen manufacturer or Zaltoprofen supplier.
PharmaCompass also assists you with knowing the Zaltoprofen API Price utilized in the formulation of products. Zaltoprofen API Price is not always fixed or binding as the Zaltoprofen Price is obtained through a variety of data sources. The Zaltoprofen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_29002 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_29002, including repackagers and relabelers. The FDA regulates DSSTox_CID_29002 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_29002 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_29002 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_29002 supplier is an individual or a company that provides DSSTox_CID_29002 active pharmaceutical ingredient (API) or DSSTox_CID_29002 finished formulations upon request. The DSSTox_CID_29002 suppliers may include DSSTox_CID_29002 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_29002 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DSSTox_CID_29002 Drug Master File in Japan (DSSTox_CID_29002 JDMF) empowers DSSTox_CID_29002 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DSSTox_CID_29002 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_CID_29002 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DSSTox_CID_29002 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DSSTox_CID_29002 Drug Master File in Korea (DSSTox_CID_29002 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_CID_29002. The MFDS reviews the DSSTox_CID_29002 KDMF as part of the drug registration process and uses the information provided in the DSSTox_CID_29002 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DSSTox_CID_29002 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_CID_29002 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DSSTox_CID_29002 suppliers with KDMF on PharmaCompass.
A DSSTox_CID_29002 written confirmation (DSSTox_CID_29002 WC) is an official document issued by a regulatory agency to a DSSTox_CID_29002 manufacturer, verifying that the manufacturing facility of a DSSTox_CID_29002 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DSSTox_CID_29002 APIs or DSSTox_CID_29002 finished pharmaceutical products to another nation, regulatory agencies frequently require a DSSTox_CID_29002 WC (written confirmation) as part of the regulatory process.
click here to find a list of DSSTox_CID_29002 suppliers with Written Confirmation (WC) on PharmaCompass.
DSSTox_CID_29002 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_29002 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_29002 GMP manufacturer or DSSTox_CID_29002 GMP API supplier for your needs.
A DSSTox_CID_29002 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_29002's compliance with DSSTox_CID_29002 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_29002 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_29002 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_29002 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_29002 EP), DSSTox_CID_29002 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_29002 USP).